Today: 7 February 2026
Subscribe
Browse Category

Analyst Ratings News 7 January 2026 - 8 January 2026

Caesars Entertainment stock jumps nearly 9% after Susquehanna upgrade — what investors watch next

Caesars Entertainment stock jumps nearly 9% after Susquehanna upgrade — what investors watch next

New York, Jan 8, 2026, 12:49 EST — Regular session Caesars Entertainment shares climbed nearly 9% in midday trade on Thursday after Susquehanna upgraded the casino operator to “Positive” and raised its price target to $31 from $25. The stock was up about 9% at $25.06. Benzinga The upgrade lands at a touchy moment for casino stocks, where any hint of softer U.S. demand has been met with fast selling. Caesars has little margin for error given its debt load, so broker calls that lean on improving trends can move the stock quickly. Susquehanna said the risk-reward looked “attractive,” arguing
8 January 2026
····
Palantir stock ticks up premarket after Truist slaps $223 target on PLTR

Palantir stock ticks up premarket after Truist slaps $223 target on PLTR

New York, Jan 8, 2026, 08:46 EST — Premarket Palantir Technologies Inc shares rose 1.1% in premarket trading on Thursday to $181.68, after closing at $179.68. The move followed Truist Securities starting coverage with a Buy rating and a $223 price target. The note matters because Palantir has become a high-multiple trade, where sentiment can swing the stock as much as a contract win. When the price runs ahead of fundamentals, new research can hit harder than usual. There is also timing. Rate expectations are in flux, and the next few data points can jolt the kind of richly valued
8 January 2026
······
Bristol Myers Squibb (BMY) stock jumps on UBS upgrade as investors look to January catalysts

Bristol Myers Squibb (BMY) stock jumps on UBS upgrade as investors look to January catalysts

New York, January 7, 2026, 20:54 (EST) — Market closed Bristol Myers Squibb shares rose 4.2% to $56.72 on Wednesday after UBS upgraded the drugmaker to buy and lifted its price target to $65 from $46. TipRanks The call matters now because big drugmakers are trying to convince investors they can bridge the next few years of patent losses without giving up growth later. Bristol Myers has been a litmus test for that trade: steady cash flows, but an earnings gap investors do not want to underwrite blindly. UBS analyst Michael Yee said the stock’s “risk/reward ratio” is “skewed… to
8 January 2026
·····
Regeneron stock pops on BofA double-upgrade as 2026 catalysts stack up

Regeneron stock pops on BofA double-upgrade as 2026 catalysts stack up

New York, Jan 7, 2026, 20:51 EST — Market closed Regeneron Pharmaceuticals shares climbed 4.6% on Wednesday after Bank of America upgraded the drugmaker to “Buy” from “Underperform” and raised its price objective to $860. Investing.com The call matters because Regeneron’s stock has been stuck in a tug-of-war: investors want proof the company can defend its eye-medicine franchise as rivals and copycat versions crowd the field, while newer products and pipeline shots sit further out. BofA wrote that earlier worries around the standard-dose version of Eylea have been priced in, and it is now leaning on a faster shift to
8 January 2026
·····
AST SpaceMobile stock slides after Scotiabank downgrade calls valuation “irrational”

AST SpaceMobile stock slides after Scotiabank downgrade calls valuation “irrational”

New York, Jan 7, 2026, 12:42 (EST) — Regular session AST SpaceMobile, Inc. (ASTS) fell 8.5% to $89.18 in midday trading on Wednesday after Scotiabank cut the satellite communications company to sector underperform. The stock opened at $91 and hit a session low of $88.49 as volume rose past 12.3 million shares. The downgrade hits after a sharp run that has pushed the stock close to its highs and made valuation the central argument. Shares have more than tripled over the past 12 months, even though the company is not expected to post positive operating profit until 2027. Barron’s Scotiabank
7 January 2026
····
Legend Biotech (LEGN) stock jumps after Oppenheimer starts coverage with $75 target

Legend Biotech (LEGN) stock jumps after Oppenheimer starts coverage with $75 target

New York, January 7, 2026, 12:32 (EST) — Regular session Shares of Legend Biotech Corp rose 7.4% to $22.53 in midday trading on Wednesday after Oppenheimer initiated coverage with an “Outperform” rating and set a $75 price target, according to MarketBeat. StreetInsider said Oppenheimer analyst Trevor Allred authored the initiation note. MarketBeat Why it matters now: Legend’s stock has been under pressure and touched a 52-week low of $21.16 earlier this week, keeping investors sensitive to any shift in the narrative around its lead product, Carvykti. Carvykti is a CAR‑T therapy — a personalized cancer treatment that uses a patient’s
7 January 2026
·····
Oracle stock (ORCL) barely moves as Jefferies sticks with $400 target

Oracle stock (ORCL) barely moves as Jefferies sticks with $400 target

New York, January 7, 2026, 11:40 ET — Regular session Oracle Corp shares slipped 0.2% to $193.44 in late-morning trading on Wednesday, after Jefferies reiterated a Buy rating and kept a $400 price target in a 2026 software outlook. Jefferies analyst Brent Thill said OpenAI accounts for 57% of Oracle’s contract backlog and argued the stock can rebound after a roughly 40% slide tied to worry about AI spending and debt. Investors The call matters because Oracle has become a test case for how much the market will pay for AI infrastructure inside a mature software name. Investors want proof
7 January 2026
·····
AppLovin (APP) stock rises as Piper Sandler sticks with $800 target and BofA keeps $860 view

AppLovin (APP) stock rises as Piper Sandler sticks with $800 target and BofA keeps $860 view

New York, January 7, 2026, 11:36 EST — Regular session AppLovin (APP.O) shares rose about 2% on Wednesday, building on a choppy start to the year as fresh analyst notes kept attention on the company’s push into e-commerce advertising. The stock was up at $629.57, while the S&P 500 was little changed and the Nasdaq-100 ETF edged higher; rival Trade Desk fell. The move matters because AppLovin’s next leg is still being priced in. Bulls are betting the company can broaden beyond mobile-game ads into web and e-commerce budgets, and the next earnings call is expected to put real numbers
7 January 2026
·····
Applied Digital stock edges up ahead of earnings as new analyst targets reach $99

Applied Digital stock edges up ahead of earnings as new analyst targets reach $99

NEW YORK, Jan 7, 2026, 10:36 EST Applied Digital shares rose about 2% on Wednesday as the AI data-center builder headed into quarterly results later in the day and drew fresh analyst coverage. The earnings print matters because investors are watching for signs that big customers are locking in power-hungry AI capacity, and whether new sites can be financed without heavy dilution. For Applied Digital, the story has shifted from one-off construction and “fit-out” work to longer lease revenue that could smooth out the numbers over time. Freedom Capital initiated coverage with a Buy rating and a $36 price target,
7 January 2026
·····
AT&T stock slips after fresh downgrade as traders brace for jobs data and Jan. 28 earnings

AT&T stock slips after fresh downgrade as traders brace for jobs data and Jan. 28 earnings

New York, Jan 7, 2026, 10:42 EST — Regular session AT&T Inc (T.N) shares fell 1.1% to $24.06 in morning trade on Wednesday after Arete Research cut the telecom stock to “sell” with a $20 price target, a list of analyst actions showed. Verizon (VZ.N) and T-Mobile (TMUS.O) also slipped, while the S&P 500 ETF was little changed. The Wall Street Journal The dip comes as traders weigh new labour-market signals that can shift rate expectations — a big deal for dividend-heavy sectors that often move with Treasury yields. ADP said U.S. private employers added 41,000 jobs in December, and
7 January 2026
····
OneStream (OS) stock drifts near $24 buyout price as analysts cut ratings — here’s what’s next

OneStream (OS) stock drifts near $24 buyout price as analysts cut ratings — here’s what’s next

New York, January 7, 2026, 10:41 EST — Regular session OneStream, Inc shares slipped 0.2% to $23.57 in morning trading on Wednesday, hovering just below the $24-a-share cash bid from buyout firm Hg Capital. The finance software maker, whose customers include Toyota and UPS, jumped more than 28% on Tuesday after the deal was announced. Reuters The all-cash deal values the finance software maker at about $6.4 billion and would hand control to an Hg-led group, with General Atlantic and Tidemark taking minority stakes, the company said. “This transaction delivers immediate value to our shareholders,” CEO Tom Shea said. KKR,
7 January 2026
·····
BigBear.ai (BBAI) stock slips premarket after Cantor downgrade — what investors watch next

BigBear.ai (BBAI) stock slips premarket after Cantor downgrade — what investors watch next

New York, Jan 7, 2026, 08:36 ET — Premarket BigBear.ai Holdings shares fell 3.6% in premarket trading on Wednesday after a Cantor Fitzgerald downgrade cooled momentum in the small-cap defense AI name. The stock was last at $6.18, after ending Tuesday up 9% at $6.41 on volume of about 93 million shares. StockAnalysis The timing matters. BigBear.ai has been moving on balance-sheet changes and deal news, and the tape has turned twitchy again just as Wall Street tries to decide whether the rally has legs or is just a squeeze-and-fade. The downgrade lands on top of an unusually tight calendar.
7 January 2026
·····
1 … 9 10 11 12 13 … 50

Stock Market Today

South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop